Safety and Tolerability Study of V501 in Japanese Boys (V501-200)

Clinical trial NCT02576054 · COMPLETED

Trial details

NCT number: NCT02576054
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Anogenital Human Papilloma Virus Infection Condyloma Acuminata

Start date: 2015-11-20
Primary completion: 2018-08-08
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.